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Abstract 
Purpose 
Most people with epilepsy (PWE) in low-income countries are not treated.  We identified 
risk factors for the epilepsy treatment gap in rural Tanzania. 
Methods 
We identified adult PWE in a community-based prevalence study.  Factors associated with 
failure to access or default from medical care were identified using logistic regression 
modelling. 
Results 
A total of 291 PWE were included, of whom 253 (86.9%) had presented to medical services.  
Failure to present was positively associated with using alcohol (odds ratio (OR) 4.20; 95% 
confidence interval (CI) 1.63 to 10.82) or attending traditional healers (OR 2.62; CI 1.00 to 
6.83) and inversely associated with having completed primary education (OR 0.33; CI 0.11 to 
0.96).  Default from treatment was associated with being male (OR 3.35; CI 1.39 to 8.09), 
having a seizure-related injury (OR 2.64; CI 1.12 to 6.19), believing in a supernatural cause 
for epilepsy (OR 5.44; CI 1.48 to 19.94) or having no expressed knowledge of cause (OR 5.29; 
CI 1.60 to 17.52).  Cases less likely to default had a duration of epilepsy greater than 10 
years (OR 0.28; CI 0.09 to 0.90) or had previously received a seizure-related diagnosis (OR 
0.25; CI 0.09 to 0.65).  Of all 291 PWE included, 118 denied taking AEDs; the epilepsy 
treatment gap in this population was therefore 40.5% (95% CI 34.9 to 46.2). 
Conclusion 
Interventions to improve access to education and to support formal diagnoses may promote 
access to, and retention under, medical care for PWE in rural Tanzania and in other low-
income countries. 
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Introduction 
Over 90% of all people with epilepsy (PWE) live in low- and middle-income countries 
(LMICs), where the majority are not treated despite the availability of effective and 
affordable medication.[1]  The epilepsy treatment gap (ETG) is defined as the proportion of 
people with active epilepsy who are not receiving treatment.[2,3]  Recent estimates of the 
ETG in LMICs have ranged from 56% to over 75%, albeit with wide confidence intervals and 
considerable heterogeneity between studies.[1,4]  A large proportion of PWE living in LMICs 
also discontinue treatment soon after initiation, a phenomenon known as the secondary 
treatment gap.[5] 
There is a paucity of data from LMICs on factors contributing to the ETG.  In a systematic 
review, eight out of 27 eligible studies presented data on causes of the ETG[1], of which 
three were from sub-Saharan Africa (SSA).[6–8]  These studies were descriptive rather than 
analytic, and two included only small numbers PWE (n=45 or 33).  Health system factors 
contributing to the ETG were cost, distance, drug availability and a lack of medically skilled 
personnel, while patient factors included non-adherence and seeking traditional rather than 
medical treatment.  This phenomenon is well-recognised in SSA, including in Tanzania, and 
is often associated with considerable costs to the patient.[9–11]  More recently, factors 
contributing to the ETG were studied among PWE living in a coastal Kenyan community, 
with traditional beliefs and negative attitudes towards medical care, distance from health 
facilities, cost, learning disability, increased duration of epilepsy and having focal seizures all 
being associated with failure to seek medical treatment.[12] 
In addition to difficulties in accessing effective treatment, epilepsy in SSA is also associated 
with social isolation and reduced life-expectancy [13,14], outcomes which may be 
exacerbated by having uncontrolled seizures, making the condition more visible and more 
dangerous.  Given access to appropriate and consistent anti-epileptic drug (AED) therapy, 
the prognosis of epilepsy can be favourable, with seizure-freedom being achievable in up to 
75% of PWE within five years of diagnosis [15,16], including for those living in 
LMICs.[11,17,18] 
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We conducted a community-based prevalence study of epilepsy in a rural district of 
northern Tanzania.  We examined factors associated with failure to access or default from 
medical treatment, our aim being to identify contributors that would potentially be 
amenable to intervention.  This is the first population-based analytical study of the ETG from 
Tanzania, and only the second study of this type from SSA.  These data should be used to 
inform policy and interventions designed to reduce the epilepsy treatment gap. 
Materials and methods 
Study site 
The Hai district lies on the slopes of Mount Kilimanjaro in northeast Tanzania, covering an 
area of approximately 1,300 km2.  Agriculture, commercial mining and cottage industries are 
the main economic activities.[19]  Hai was established as a demographic surveillance site 
(DSS) by the Tanzanian Adult Morbidity and Mortality Project in 1994 [20], and thus 
represents a well-defined study population.  The DSS is comprised of 59 villages, with a total 
population after the most recent census in 2009 of 161,119 people living in 43,794 
households.  Government-funded healthcare in the district is delivered via three tiers: 24 
dispensaries catering for village to ward level (up to 10,000 inhabitants), four health centres 
at administrative divisional level (up to 50,000 inhabitants) and one district hospital.[21]  
The AEDs phenobarbitone and phenytoin are available in village dispensaries and 
carbamazepine is available at Hai District Hospital.  At the time of the study, PB was also 
available to patients via the Mental Health Association of Tanzania, a non-governmental 
organisation providing support to patients with various psychiatric disorders, at a cost price 
of 15 Tanzanian Shillings (TSh) per 30mg tablet.  At this price the annual cost to a patient 
taking 120mg of PB per day would be 21,900 TSh, or about 10 US Dollars (USD).  Neurology 
services are available at Kilimanjaro Christian Health Centre (KCMC), a large referral hospital 
in the nearby town of Moshi.  Sodium valproate is also available at KCMC. 
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Participants and study design 
During 2009 and 2010 adult PWE aged 15 years or above were identified in a door-to-door 
prevalence study in the Hai DSS.  Epilepsy diagnoses were confirmed by the research doctor 
(EH), with active epilepsy being defined either as either having two or more unprovoked 
seizures at least 24 hours apart during the past five years, or currently using AEDs.   Seizures 
and epilepsies were classified according to currently recommended criteria.[22]  Full details 
of the prevalence study have been published elsewhere.[23] 
All PWE completed a standard questionnaire which asked about current or previous access 
to medical care and/or AED treatment, use of traditional healers or medications, and the 
associated costs of any treatments used.  From cases taking AED treatment, we sought to 
ascertain the identity, dose and pattern of use of AEDs.  Where drug names could not be 
spontaneously volunteered, prompts were offered and, wherever possible, any patient-held 
and/or health facility records or prescriptions were scrutinised.  The ETG was defined as all 
cases with active epilepsy who were not taking any form of AED treatment at the time of 
the study. 
The questionnaire was derived from a proforma designed to collect standardised data in 
epidemiological studies of epilepsy in tropical low-income countries.[24]  This tool has 
previously been used in several surveys conducted Africa.[25]  Additional items relating to 
seizure severity, including a history of seizure-related injuries, were drawn from the 
Liverpool Seizure Severity Score [26]; pragmatic categories quantifying seizure frequency 
were drawn from a related study of seizure severity and quality of life.[27]  The research 
doctor conducted all interviews in the field, assisted by a UK medical student (SC).  A 
Tanzanian research nurse (JR) provided interpretation between English and Kiswahili.  
Interviews were held in private at a local health facility, other community centre or in the 
homes of PWE.  A collateral history from a relative or carer was also taken wherever 
possible. 
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Statistical analysis 
Data were analysed using the Statistical Package for Social Sciences (SPSS) version 20.  We 
used Pearson’s χ2 to measure associations between demographic, clinical, patient and 
healthcare-related variables and two binary outcomes: previous presentation to medical 
services and, for those who had presented previously, self-reported current AED use.  We 
further investigated univariate associations with each of the two outcomes using 
multivariable binary logistic regression models constructed using a backwards stepwise 
elimination strategy based on the likelihood ratio test.  Predictor variables with a p-value of 
>0.1 were excluded at each step; those with a value of ≤0.05 were retained in the final 
models.  Missing values were considered to being missing completely at random and we did 
not impute for missing data.  The 95% confidence interval (CI) for the ETG was calculated for 
a binomially-distributed observation using the standard error of a proportion. 
Ethics 
The ethics review committee of the Tanzanian National Institute of Medical Research 
approved the study (ref. NIMR/HQ/R.8a/Vol.IX/786; 09/02/2009).  Written informed 
consent was obtained from all PWE participating in the study.  All PWE identified during the 
study were either started on treatment or were counselled in order to optimise treatment, 
in liaison with the Hai District Community Health Management Team. 
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Results 
Participants 
Two-hundred and ninety-one PWE were included in the study: 155 (53.3%) were male and 
the median age of all cases was 30 years (range 15 to 85 years; IQR 21 years).  All PWE 
included in the study were suffering from active convulsive epilepsy with either primary or 
secondary generalisation, with no cases of non-convulsive epilepsy identified. 
Access to medical care 
A total of 253 cases (86.9%) had previously sought medical attention, 173 (68.4%) of whom 
stated they were taking treatment at the time of the study (59.5% of all cases).  
Demographic and clinical characteristics of these groups along with univariable ORs for 
seeking medical treatment and self-reported AED treatment are summarised in Tables 1 and 
2.  Binomial multivariable logistic regression models are summarised in Table 3.  Cases 
identified as less likely to have sought medical treatment were those who had used 
traditional treatment (odds ratio (OR) for failure to seek treatment 2.62; 95% CI 1.00 to 
6.83) or who drank alcohol (OR 4.20; 95% CI 1.63 to 10.82), while having completed primary 
education was a protective factor (OR 0.33; 95% CI 0.11 to 0.96) (Table 3).  Among cases 
who had previously presented, factors associated with non-treatment were being male (OR 
3.35; 95% CI 1.39 to 8.09), having a seizure-related injury (OR 2.64; 95% CI 1.12 to 6.19), 
believing that epilepsy has a supernatural cause (OR 5.44; 95% CI 1.48 to 19.94), having no 
expressed idea as to the cause (OR 5.29; 95% CI 1.60 to 17.52) or using alcohol (OR 3.93; 
95% CI 1.29 to 12.01).  Protective factors in this group were having epilepsy for 10 years or 
more (OR 0.28; 95%CI 0.09 to 0.90) and having previously been given a seizure-related 
diagnosis (OR 0.25; 95% CI 0.09 to 0.65) (Table 4).  Of 102 cases with seizure-related injuries, 
76 (74.5%) had burns.  Seizure-related diagnoses included the Kiswahili terms kifafa or 
degedege.  Kifafa is usually translated as meaning epilepsy, although in our experience is 
used to refer more specifically to generalised convulsive episodes with frothing at the 
mouth; degedege is usually translated as referring to febrile seizures in children, although is 
often used interchangeably with kifafa. 
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Current AED use and treatment gap 
Out of the 291 PWE identified, 118 denied taking AEDs at the time of the study, and a 
conservative estimate of the ETG is therefore 40.5% (95% CI 34.9 to 46.2). 
Out of 173 PWE who stated they were taking treatment, 147 (85.0%) were using one drug 
and 26 (15.0%) were using two in combination.  Phenobarbitone (PB) was the most 
commonly identified AED, used by 134 (77.5%) of all treated cases.  Other AEDs 
encountered were phenytoin (PHT) (28 cases, 16.2%), carbamazepine (CBZ) (22 cases, 
12.7%) and sodium valproate (SV) (two cases, 1.2%).  In 13 (7.5%) cases, we could not 
confidently identify the drug(s) used.  The patterns of AED use are illustrated in Figures 1 
and 2. 
Data on self-reported compliance were available in 168 (97.1%) cases, of whom 122 (70.5%) 
were taking treatment daily when available, although 30 (24.6%) of these were using doses 
likely to be sub-therapeutic.  The remainder were taking treatment only very infrequently; 
four cases (2.3%) reported taking AEDs only after a seizure had occurred. 
Data on side effects from AED treatment were available in 159 (91.9%) of 173 treated cases, 
with 134 (84.3%) of these reporting no adverse effects.  Of the 25 individuals that did report 
side effects, 17 cases complained of tiredness (13 using PB mono-therapy, three using PB 
and PHT, and one using an unidentified drug).  Other adverse effects reported included 
dizziness (four cases on PB mono-therapy, one on an unidentified drug), headache (two 
cases, both using PB), rash (one case using CBZ and SV), memory problems (one case using 
PB), and unspecified behavioural disturbance (one case using PB). 
Data on cost of AEDs were available from 146 (84.4%) cases, of whom 96 (65.8%) purchased 
their medication privately. 
The majority of treated cases had poorly controlled seizures, with only 20 (11.6%) reporting 
to be seizure-free (defined as no seizures in the previous five years).  Of the 153 treated 
cases with active seizures, 100 (65.4%) reported seizures on at least a monthly basis (Figure 
3). 
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Traditional treatment 
Data on the use of traditional treatment were available from 276 (94.8%) cases, of whom 
133 (48.2%) had attended a traditional healer at some point.  Of these, 90 (67.7%) could 
recall details of the diagnosis or explanation given to them by traditional healers: no specific 
explanation was given in 33 cases (36.7%), a supernatural explanation was used in 23 cases 
(25.6%), 13 (14.4%) were diagnosed as degedege and 10 (11.1%) as kifafa; 11 cases (12.2%) 
described a range of other explanations relating to various physical or emotional causes.  
Eighty-five people provided an estimate of the cost to themselves or their families of 
traditional treatment, with 20 (23.5%) having spent at least 100,000 Tanzanian Shillings 
(about 50 USD), often selling livestock or other possessions to raise funds.  Modes of 
treatment described included taking inhalations and purgatives, wearing amulets and 
talismen, participating in spiritual ceremonies and scarification. 
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Discussion 
The ETG in adult PWE living in this part of Tanzania is 40.5%.  This is considerably lower than 
recent estimates from comparable populations in this region.  Elsewhere in northern 
Tanzania, for example, 76% of PWE identified in a community-based study had never 
received AED treatment, despite living close to a hospital where AEDs are available [28]. 
 The lower ETG in Hai may be due in part to its proximity to the large towns of Arusha and 
Moshi, where numerous private clinics and non-governmental healthcare providers are 
located, and to a large referral hospital (KCMC), where neurology services are available.  The 
influence of bias, however, must also be considered.  Firstly, we know that epilepsy is a 
highly stigmatising condition in this population [13], and it can be assumed that more 
marginalised individuals are less likely to have been detected by the study.  Secondly, our 
prevalence study detected only PWE with active convulsive epilepsy [23], reflecting the 
difficulty in identifying non-convulsive epilepsy in door-to-door surveys in low-income 
settings.  This issue has previously been acknowledged in study design [29], and is reflected 
in the consistently low proportions of non-convulsive epilepsies that have been described in 
community-based cross-sectional studies.[30]  It can be assumed that PWE belonging to 
either or both of these groups are less likely to be diagnosed and treated and would, 
therefore, have contributed to the ETG estimate had they been included.  Finally, the utility 
of self-reporting in estimating the ETG has recently been questioned by a study from Kenya 
in which self-reported adherence had a sensitivity and specificity of 38.1% and 80.8% when 
compared to detection of AEDs in blood.[12]  With these potential biases in mind, and 
considering the high proportion of treated patients who were taking AEDs only very 
infrequently, along with the large burden of uncontrolled and frequent seizures observed in 
this group of PWE, we suggest that the ETG in Hai of 40.5% is likely to represent a 
considerable underestimate of those not receiving appropriate or regular treatment. 
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Beyond estimating the ETG, we sought to identify factors associated with access and 
adherence, components of the ETG that may have different implications in terms of 
interpretation and, ultimately, intervention.[31]  Cases less likely to have presented to 
medical services were those who had visited traditional healers and those who used alcohol; 
having completed primary education was associated with a greater likelihood of having 
sought medical treatment.  While lack of education and alcohol use could represent socio-
economic markers predictive of a lower level of engagement with services in general, they 
may also be factors that are present more frequently as the result of having epilepsy.  With 
regards to education, we are more inclined to believe the latter, as qualitative studies of 
adults and children with epilepsy in this population have identified exclusion from school 
due to epilepsy as a recurring theme.[13,32]  This is supported by quantitative data locally, 
with 50% of children with epilepsy in the Hai DSS not attending school regularly compared 
to none of a group of age-matched controls[33], while elsewhere in Africa 43.2% of 2,170 
PWE in five countries (Ghana, Kenya, South Africa, Tanzania and Uganda) reported lack of 
education, almost double the proportion seen in controls.[34]  Improving access to 
education for PWE may therefore be an intervention that helps to reduce the ETG in the 
long term, and for this reason we are currently pursuing public engagement activities with 
parents and teachers in order to further understand these issues.[35] 
Only 38.3% of PWE who had previously sought treatment in this population recalled 
receiving a diagnosis compatible with epilepsy or seizures.  The fact that continued use of 
AEDs is associated with having received a diagnosis speaks plainly to the need to equip local 
healthcare workers with the knowledge, skills and confidence to make what may be a very 
stigmatising diagnosis.  It has been proposed that interventions at a local level should 
address the training of health care workers, enabling them to diagnose and manage 
epilepsy, to counsel PWE about their diagnoses, and to make appropriate referrals.[36]  
Such programmes have been successful in improving the diagnosis and management of 
epilepsy in communities in India, Zimbabwe and Ethiopia.[37–39]  In communities similar to 
Hai, where nearly one third of PWE that initially present to treatment services are not 
retained, such educational interventions would clearly also be appropriate. 
Other than alcohol use, a different set of associations with default from treatment were 
observed.  Men were more than three times more likely to default than women, an 
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association that has not been described previously in the epilepsy literature from low-
income countries.  Contributory factors not measured and/or adjusted for in our study may 
include a poorer initial response to treatment, economic reasons or stigma.  It may also be 
that women benefit from additional protective factors with regards to engaging with 
treatment.  It has been suggested, for example, that women in Tanzania are more health-
conscious then men, being accustomed to attending maternity and child-care clinics and 
speaking openly about health issues.[28]  This may contribute to increased retention under 
care for chronic conditions such as epilepsy.  Further work is warranted to reproduce this 
result in other populations and to further understand the specific barriers to long-term 
treatment faced by men with epilepsy in SSA.  
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Individuals who had suffered a seizure-related injury (most frequently burns) were more 
than twice as likely to default.  This contrasts with data from elsewhere in Africa which 
suggest a positive association between current AED treatment and burns.[34]  While our 
finding may point to the higher risk of injury in untreated epilepsy we were also told during 
field work, anecdotally and on numerous occasions, that when a PWE sustains a burn this 
would be taken as a sign that the condition had become untreatable.  It may be that this 
apparently commonly held belief leads to default rather than encouraging compliance.  
Further investigation of such cultural issues, and of the temporal association between the 
incidence of injury and adherence to treatment, is warranted. 
Individuals who believed either that epilepsy has a supernatural cause or who had no 
expressed knowledge of the cause were five times more likely to default.  Taking this 
together with the observed association between failure to access treatment and use of 
traditional healers, we suggest that community-level sensitisation and education are 
warranted in order to increase the likelihood of incident cases presenting to medical 
services and continuing with treatment.  In support of this, it has been demonstrated that 
supernatural and medical ideas about the causes of epilepsy can co-exist in African 
communities [10], and there are also precedents for establishing collaborative relationships 
between medical services and traditional healers.[40]  In order to be successful, such 
initiatives would require sound ethnographic understanding of such treatment providers 
and their place within the community.[41] 
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Factors associated with a reduced likelihood of default from treatment in our study were 
having epilepsy for more than 10 years, and having previously received a diagnosis 
compatible with seizures or epilepsy.  The first of these findings contrasts with those of a 
cross-sectional study of the risk factors associated with the ETG in rural Kenya.[12]  Failure 
to seek treatment in that study was associated with duration of epilepsy of 10 years or 
more, while AED use of greater than five years was associated with non-adherence.  While 
the authors postulate that PWE with a longer duration of epilepsy may have learned to cope 
with their condition, our alternative finding could indicate that people who have lived with 
epilepsy for longer may have learned the benefits of treatment.  It may also be that those 
PWE who do not comply with treatment are less likely to survive with epilepsy for 10 years.  
We are following our cohort prospectively with regards to mortality, amongst other 
outcomes, and may be able to clarify this issue.  Finally, it must also be considered that 
these contradictory findings, which are difficult to interpret, may also be spurious 
associations seen as a result of residual confounding that has not been controlled for in the 
analysis. 
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At least 65.8% of PWE taking AED treatment were buying their own drugs.  Although the 
local cost of PB, used by 77.5% of PWE, was potentially as little as 10 USD per year, 
availability and affordability are nevertheless likely to be factors contributing to the ETG in 
this population, where nearly one half of people live on less than 1.90 USD a day, measured 
against 2011 international prices.[42]  This assumption is supported by a secondary analysis 
of health-facility based surveys in 34 LMICs, including Tanzania, in which the availability of 
all AEDs in the public sector was less than 50% and adjusted per patient costs of generic 
AEDs were up to 17.5 times higher than international reference prices.[43]  Furthermore, 
cost was found to be an independent predictor of failure to seek medical treatment among 
PWE living in rural Kenya.[12]  Our limited data on traditional treatment also suggest that 
many patients are faced with significant upfront costs, which may represent catastrophic 
spending for families living below the poverty line.  Although AEDs are available locally, 
either for free or at relatively low cost, problems of availability coupled with the poor 
treatment outcomes we observed may mean that they are not seen as being a viable 
alternative to traditional treatment, or one that represents better value for money.  These 
issues warrant further investigation, particularly as financial protection is one of the tenets 
of universal health coverage now being promoted by the WHO as part of the post-2015 
development agenda.[44] 
In treated cases with uncontrolled seizures, 30.1% reported having seizures at least weekly 
and 65.4% at least monthly.  Retrospective reporting of seizure frequency at up to two 
months has been shown to be consistent between patients and carers [45], and the high 
seizure frequencies among PWE in Hai point to a need to further optimise treatment for 
those who are taking AEDs.  Conversely, 11.6% of cases who stated that they were taking 
treatment reported that they had been free of seizures for five years or more.  This group of 
patients represents the challenge of advising on and supervising a safe withdrawal of 
treatment in this context.  While it has been demonstrated in the UK that 59% of PWE who 
have been seizure-free for two years while taking AEDs will remain in remission following 
withdrawal of treatment, there are no comparable data from Africa and little published 
clinical experience.  Encouragingly, in Ethiopia 20% of 64 patients who had stopped 
attending a nurse-led epilepsy clinic were found to be in remission off treatment.[39] 
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The majority of cases using AEDs (84.3%) did not report any side effects, and none 
complained of serious problems leading to withdrawal of treatment.  This corresponds with 
other observational studies conducted in resource-poor settings, including SSA, which have 
consistently demonstrated the efficacy and tolerability of PB in routine clinical use.[15, 
45,46]  The Hai cohort is now under follow-up, allowing for prospective evaluation of 
treatment outcomes, including adherence, tolerability and efficacy. 
Our study had several limitations.  Due to limited resources, we were unable to collect 
objective data on distance from health facilities, the importance of which is well 
recognised.[12,25]  Similarly we could not validate our estimate of the ETG through 
comparison of self-reported treatment with blood levels of AEDs, which has been shown to 
be meaningful.[12]  Furthermore, we did not use any standardised measure of adherence, 
although this was not helpful when compared with measurement of AEDs in blood in the 
Kenyan study cited above.  As our study was questionnaire-based, reporting and recall bias 
are likely to have occurred, and the influence on our findings of data missing at random is 
difficult to assess.  To the best of our knowledge, however, this is the first community-based 
study of epilepsy in this population, and despite the acknowledged limitations represents a 
valuable baseline assessment of the experience of PWE in this part of Tanzania. 
Conclusion 
Despite the availability of effective and affordable drugs, at least two fifths of PWE in this 
rural area of Tanzania are not currently taking regular AED treatment.  We have identified a 
combination of patient- and healthcare-related factors associated with failure to seek and 
default from medical treatment.  Some of these are potentially modifiable through 
educational interventions targeting patients, healthcare workers and the community.  Any 
interventions should, however, be informed by further detailed and nuanced 
characterisation of the various factors influencing treatment-seeking and delivery of care.  A 
deeper understanding these issues will benefit PWE in the Hai DSS as well as elewhere in 
Tanzania, SSA and low-income countries in general. 
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Tables and figures 
Table 1: Univariable associations with failure to seek medical treatment for epilepsy 
 
  
 Previously sought medical treatment  
Odds ratio (95% CI) 
p-
value 
Yes (N=253) No (N=38)  
 n  (%) n  (%)  
Demographic factors             
Age band             
15-24 91  (36.0) 12  (31.6)  1.0       
25-34 60  (23.7) 7  (18.4)  1.14 ( 0.25 to 5.16 ) 0.87 
35-44 41  (16.2) 8  (21.1)  2.25 ( 0.40 to 12.74 ) 0.36 
45-54 33  (13.0) 5  (13.2)  0.81 ( 0.09 to 7.37 ) 0.85 
55+ 16  (6.3) 4  (10.5)  0.56 ( 0.06 to 4.79 ) 0.59 
Male sex (vs. Female) 132  (52.2) 23  (60.5)  0.97 ( 0.33 to 2.81 ) 0.95 
Christian (vs. Muslim) 199  (78.7) 24  (63.2)  0.57 ( 0.16 to 2.02 ) 0.39 
Missing values 8  (3.2) 1  (2.6)         
Chagga tribe (vs. Other) 194  (76.7) 26  (68.4)  1.26 ( 0.31 to 5.13 ) 0.75 
Missing values 12  (4.7) 4  (10.5)         
Education             
None/incomplete primary 113  (44.7) 22  (57.9)  1.0       
Complete primary 103  (40.7) 8  (21.1)  0.20 ( 0.04 to 0.97 ) 0.05 
Any secondary/tertiary 27  (10.7) 1  (2.6)  0.17 ( 0.01 to 2.27 ) 0.18 
Missing values 10  (4.0) 7  (18.4)         
Literate (vs. Not literate) 126  (49.8) 15  (39.5)  1.23 ( 0.27 to 5.51 ) 0.79 
Missing values 9  (3.6) 6  (15.8)         
Marital status             
Single (never married) 159  (62.8) 19  (50.0)  1.0       
Married/widowed 67  (26.5) 14  (36.8)  1.55 ( 0.30 to 7.95 ) 0.60 
Divorced/separated 19  (7.5) 3  (7.9)  1.84 ( 0.20 to 16.92 ) 0.59 
Missing values 8  (3.2) 2  (5.3)         
Main occupation             
Farming/herding 80  (31.6) 16  (42.1)  1.0       
Trade/skill/salaried 30  (11.9) 3  (7.9)  0.84 ( 0.16 to 4.47 ) 0.84 
Other 81  (32.0) 7  (18.4)  0.31 ( 0.06 to 1.50 ) 0.15 
Unable to work 58  (22.9) 11  (28.9)  0.81 ( 0.14 to 4.62 ) 0.81 
Missing values 4  (1.6) 1  (2.6)         
             
Clinical factors             
Duration of epilepsy             
≤5 years 41 (16.2) 8  (21.1)  1.0       
6-10 years 33  (13.0) 8  (21.1)  1.96 ( 0.24 to 16.22 ) 0.53 
>10 years 174  (68.8) 20  (52.6)  1.14 ( 0.17 to 7.77 ) 0.89 
Missing values 5  (2.0) 2  (5.3)         
Focal-onset seizures (vs. Gen./undefined) 181  (71.5) 27  (71.1)  0.67 ( 0.21 to 2.13 ) 0.50 
Seizure-related Injury (vs. No injuries) 90  (35.6) 12  (31.6)  0.50 ( 0.15 to 1.67 ) 0.26 
Cognitive impairment (vs. No impairment) 75  (29.6) 13  (34.2)  0.98 ( 0.18 to 5.18 ) 0.98 
Family history of epilepsy (vs. None) 44  (17.4) 7  (18.4)  1.29 ( 0.38 to 4.36 ) 0.68 
             
Patient/healthcare-related factors             
Beliefs about cause of epilepsy             
Medical cause 45  (17.8) 5  (13.2)  1.0       
Supernatural cause 62  (24.5) 9  (23.7)  1.59 ( 0.37 to 6.76 ) 0.53 
Doesn’t know 110  (43.5) 10  (26.3)  0.93 ( 0.25 to 3.48 ) 0.92 
Missing values 36  (14.2) 14  (36.8)         
Traditional treatment (vs. No trad. Rx) 112  (44.3) 21  (55.3)  2.81 ( 0.92 to 8.59 ) 0.07 
Missing values 10  (4.0) 5  (13.2)         
Drinks alcohol (vs. Doesn’t drink) 40 (15.8) 13 (34.2)  4.33 ( 1.30 to 14.40 ) 0.02 
19 
 
 Self-reported current 
treatment 
 Odds Ratio (95% CI) p-
value 
Yes (N=173) No (N=80)  
 n (%) n (%)  
Demographic factors             
Age band             
15-24 63 (36.4) 28 (35.0)  1.00        
25-34 43 (24.9) 17 (21.3)  0.76 ( 0.23 to 2.55 ) 0.66 
35-44 27 (15.6) 14 (17.5)  0.94 ( 0.17 to 5.13 ) 0.95 
45-54 24 (13.9) 9 (11.3)  1.53 ( 0.28 to 8.38 ) 0.62 
55+ 16 (9.2) 12 (15.0)  1.15 ( 0.24 to 5.48 ) 0.86 
Male sex (vs. Female) 82 (47.4) 50 (62.5)  3.70 ( 1.38 to 9.94 ) 0.009 
Christian (vs. Muslim) 138 (79.8) 61 (76.3)  0.49 ( 0.15 to 1.45 ) 0.19 
Missing values 5 (2.9) 3 (3.8)         
Chagga tribe (vs. Other) 136 (78.6) 58 (72.5)  0.80 ( 0.26 to 2.47 ) 0.70 
Missing values 6 (3.5) 6 (7.5)         
Education             
None/incomplete primary 73 (42.2) 40 (50.0)  1.00       
Complete primary 75 (43.4) 28 (35.0)  0.61 ( 0.19 to 2.01 ) 0.42 
Any secondary/tertiary 18 (10.4) 9 (11.3)  0.51 ( 0.08 to 3.10 ) 0.46 
Missing values 7 (4.0) 3 (3.8)         
Literate (vs. Not literate) 88 (50.9) 38 (47.5)  0.71 ( 0.21 to 2.44 ) 0.59 
Missing values 6 (3.5) 3 (3.8)         
Marital status             
Single/never married 112 (64.7) 47 (58.8)  1.00       
Married/widowed 41 (23.7) 26 (32.5)  1.67 ( 0.37 to 7.52 ) 0.51 
Divorced/separated 14 (8.1) 5 (6.3)  0.58 ( 0.07 to 5.18 ) 0.63 
Missing values 6 (3.5) 2 (2.5)         
Main occupation             
Farming/herding 55 (31.8) 25 (31.3)  1.00       
Trade/skill/salaried 22 (12.7) 8 (10.0)  0.40 ( 0.07 to 2.24 ) 0.30 
Other 56 (32.4) 25 (31.3)  2.52 ( 0.74 to 8.54 ) 0.14 
Unable to work 36 (20.8) 22 (27.5)  2.55 ( 0.62 to 10.49 ) 0.20 
Missing values 4 (2.3) 0 (0.0)         
             
Clinical factors             
Duration of epilepsy             
≤5 years 24 (13.9) 17 (21.3)  1.00       
6-10 years 20 (11.6) 13 (16.3)  0.76 ( 0.18 to 3.17 ) 0.71 
>10 years 126 (72.8) 48 (60.0)  0.27 ( 0.06 to 1.15 ) 0.08 
Missing values 3 (1.7) 2 (2.5)         
Focal-onset seizures (vs. Gen./undefined) 121 (69.9) 60 (75.0)  0.69 ( 0.24 to 1.96 ) 0.49 
Seizure-related injuries (vs. No injury) 61 (35.3) 29 (36.3)  3.50 ( 1.32 to 9.25 ) 0.01 
Cognitive impairment (vs. No impairment) 48 (27.7) 27 (33.8)  2.03 ( 0.65 to 6.31 ) 0.22 
Family history of epilepsy (vs. No history) 31 (17.9) 13 (16.3)  0.68 ( 0.20 to 2.26 ) 0.53 
             
Patient/healthcare-related factors             
1st presentation ≤1 year from onset (vs. >1 
year) 
63 (36.4) 33 (41.3)  1.15 ( 0.47 to 2.81 ) 0.77 
Missing values 16 (9.2) 12 (15.0)         
Previous diagnosis             
None/no recall 70 (40.5) 44 (55.0)  1.00       
Epilepsy/kifafa/degedege 78 (45.1) 19 (23.8)  0.24 ( 0.09 to 0.66 ) 0.006 
Other 23 (13.3) 16 (20.0)  2.11 ( 0.65 to 6.85 ) 0.22 
Missing values 2 (1.2) 1 (1.3)         
Beliefs about cause of epilepsy             
Medical cause 36 (20.8) 9 (11.3)  1.00       
Supernatural cause 42 (24.3) 20 (25.0)  9.10 ( 2.01 to 41.23 ) 0.004 
Doesn’t know 78 (45.1) 32 (40.0)  7.52 ( 1.96 to 28.85 ) 0.003 
Missing values 17 (9.8) 19 (23.8)         
Traditional treatment (vs. No trad. Rx) 79 (45.7) 33 (41.3)  0.78 ( 0.31 to 1.97 ) 0.60 
Missing values 7 (4.0) 3 (3.8)         
Drinks alcohol (vs. Doesn’t drink) 17 (9.8) 23 (28.7)  4.91 ( 1.36 to 17.64 ) 0.02 
Table 2: Univariable associations with default from treatment having previously presented 
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 Adj. OR   (95% CI)  p-value 
Failure to present 
Demographic factors          
Completed primary education 0.33  ( 0.11 to 0.96 )  0.04 
          
Patient/healthcare-related factors          
Traditional healer/treatment 2.62  ( 1.00 to 6.83 )  0.05 
Drinks alcohol 4.20  ( 1.63 to 10.82 )  0.003 
 
Default from treatment 
Demographic factors          
Male sex 3.35  ( 1.39 to 8.09 )  0.007 
          
Clinical factors          
Duration of epilepsy > 10 years 0.28  ( 0.09 to 0.90 )  0.03 
Seizure-related injury 2.64  ( 1.12 to 6.19 )  0.03 
          
Patient/healthcare-related factors          
Prev. seizure diagnosis (kifafa/degedege/other) 0.25  ( 0.09 to 0.65 )  0.004 
Believes aetiology supernatural 5.44  ( 1.48 to 19.94 )  0.01 
No ideas/knowledge of aetiology 5.29  ( 1.60 to 17.52 )  0.006 
Drinks alcohol 3.93  ( 1.29 to 12.01 )  0.02 
Table 3: Multivariable models of factors associated with failure of PWE to seek treatment, 
and default from treatment in those who have previously presented 
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Figure 1: Pattern of AED monotherapy in adult PWE in the Hai DSS (n=147) 
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Figure 2: Pattern of AED dual therapy in adult PWE in the Hai DSS (n=26) 
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Figure 3: Cumulative seizure frequency in PWE with active seizures reporting to be taking 
AEDs (N=153) 
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